We are a world-leading cancer research institute, a charity, and a member institution of the University of London. Public donations and clinical partnerships are helping us to make the discoveries ...
Nia Haware and Marcia Pennant work jointly as Legacy Marketing Officers in our Development and Communications Office.
Need to find a specific expert or member of a research group or division? Just search by role, division, name or browse our researchers A-Z.
I am a Higher Scientific Officer in the Translational Therapeutics Team at the ICR. My focus is on leveraging apoptotic pathways to combat therapy resistance and study immunogenic responses.
Esther is a Research Administrator working within Professor Clare Turnbull’s team in Genetics and Epidemiology at the Institute of Cancer Research. Esther joined the ICR in 2024 to support the ...
Zeid Kuzbari is a bioinformatician with a research focus on NGS whole-exome analyses of testicular germ cell tumours and breast cancer. He is also currently working on the implementation of functional ...
Twenty years ago today, the International Genome Sequencing Consortium published the first detailed analysis of the human genome. The paper appeared online in Nature on 15 February 2001, followed by a ...
Last month, DeepMind published the much anticipated, detailed methodology underlying the latest version of AlphaFold – the UK-based science company’s powerful AI system that blew away its rivals in ...
Two decades ago, a pivotal exchange between two scientists sparked a scientific and medical revolution. Professor Alan Ashworth, then Director of the Breast Cancer Now Toby Robins Research Centre at ...
The overuse of CT scans could cause over 100,000 cases of cancer in the US – with almost 10,000 cases in children, researchers have warned. According to a new modelling study, published in the journal ...
The Institute of Cancer Research, London, strongly welcomes the decision by NICE to recommend the targeted breast cancer drug, capivasertib, in combination with fulvestrant, for treating the most ...
A blood test can predict how well patients with advanced breast cancer will respond to targeted therapies – before treatment begins, according to new research. A team from The Institute of Cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results